Term
List of Inhibitors of Acetylcholine Synthesis, Storage, and Release |
|
Definition
Hemicholinium-3
Vesamicol
Botulinum toxin |
|
|
Term
|
Definition
Utilized only in research settings. Blocks the high-affinity transporter for choline and thereby prevents the uptake of choline required for ACh synthesis. |
|
|
Term
|
Definition
Utilized only in research settings. Blocks the ACh-H+ antiporter that is used to transport ACh into vesicles. |
|
|
Term
Botulinum toxin, applications, adverse effects, contraindications, therapeutic consideration |
|
Definition
Focal dystonias, torticollis, achalasia, strabismus, blepharospasm, pain syndromes, wrinkles, hyperhidrosis
Cardiac arrhythmia, syncope, hepatotoxicity, anaphylaxis, injection-site pain, dyspepsia, dysphagia, muscle weakness, neck pain, eyelid ptosis, fever
hypersensitivity and injection site infection
Produced by Clostridium botulium, degrades synaptobrevin and thus prevents synaptic vesicle fusion with axon terminal (presynaptic) membrane |
|
|
Term
List of Inhibitors of Acetylcholine Degradation |
|
Definition
Edrophonium
Neostigmine
Pyridostigmine
Ambenonium
Physostigmine
Diisopropyl fluorophosphate
Tacrine
Donepezil
Rivastigmine
Galantamine |
|
|
Term
Mechanism of Acetylcholine Degradation |
|
Definition
Inhibit acetylcholinesterase (AChE) by binding to the enzyme's active site. |
|
|
Term
Edrophonium, Neostigmine, Pyriddostigmine, Ambenonium, Physostigmine: applications. |
|
Definition
Diagnosis of myasthenia gravis, Eaton-Lambert syndrome, and disorders resulting in muscle weakness (edrophonium)
Urinary or gastrintestinal motility agent, glaucoma, neuromuscular junction diseases such as myasthenia gravis (neostigmine, pryridostigmine, ambenonium)
Reversal of anticholinergic toxicity or induced paralysis in surgery (physostigmine) |
|
|
Term
Edrophonium, Neostigmine, Pyriddostigmine, Ambenonium, Physostigmine, adverse effects |
|
Definition
Seizure, bronchospasm, cardiac arrhythmia, bradycardia, cardiac arrest, hypotension or hypertension, salivation, lacrimation, diaphoresis, vomiting, diarrhea, miosis |
|
|
Term
Edrophonium, Neostigmine, Pyriddostigmine, Ambenonium, Physostigmine, contraindications, therapeutic considerations. |
|
Definition
Mechanical intestinal or urinary obstruction. Concomitant choline ester or depolarizing neuromuscular block use. Cardiovascular disease.
-Edrophonium is short-acting (2-10 mins); rapid onseet of action makes it useful for diagnosis of muscle weakness.
-For chronic treatment of myasthenia gravis, longer-action cholinesterase inhibitors such as pyridostigmine, neostigmine, and ambenonium are preferred.
-Neostigmine also has direct cholinergic agonist effect at Nm receptors.
-Topical application of cholinesterase inhibitor to the cornea of the eye decreases intraocular pressure by facilitating the outflow of aqueous humor
-Nonpolar structure makes physostigmine useful for treating CNS anticholinergic toxicity |
|
|
Term
Diisopropyl fluorophosphate, applications, adverse effects, contraindications, therapeutic considerations |
|
Definition
Not applicable (sometimes encountered as a toxin)
Respiratory paralysis, bradycardia, bronchospasm, fasciculations, muscle cramps, weakness, CNS depression, agitation, confusion, delirium, coma, bronchorrhea, salivation, lacrimation, diaphoresis, vomiting, diarrhea, miosis
Not applicable
An organophosphate compound used as an insecticide, as a substrate for the production of organophosphate chemical weapons (nerve gases), and formerly as a topical miotic medication in ophthalmology |
|
|
Term
Tacrine, Donepezil, Rivastigmine, Galantamine, applications, adverse effects, contraidications, therapeutic considerations. |
|
Definition
Mild to moderate Alzheimer's disease and dementia
Diarrhea, nausea, vomiting, cramps, anorexia, vivid dreams
Treatment-associated liver function test abnormalities (tacrine)
-Modest symptomatic benefits in Alzheimer's disease.
-Rivastigmine affects both acetylcholinesterase and butyrylcholinesterase by forming a carbamoylate complex with the enzymes.
-Galantamine also acts as a nonpotentiating ligand of nicotinic receptors |
|
|
Term
List of Muscarinic Agonists |
|
Definition
Methacholine
Carbachol
Bethanechol
Cevimeline
Pilocarpine |
|
|
Term
Methacholine, applications, adverse effects, contraindications, therapeutic considerations. |
|
Definition
Asthma
Dyspnea, lightheadedness, headache, pruritus, throat irritation
Recent heart attack or stroke, aortic aneurysm, uncontrolled hypertension
Highly resistant to acetylcholinesterase; it is relatively selective for cardiovascular muscarinic cholinergic receptors. |
|
|
Term
Carbachol, Bthanechol, Cevimeline, Pilocarpine, applications, adverse effects, contraindications. |
|
Definition
Glaucoma (carbachol), urinary tract motility agent (bethanechol), Xerostomia in Sjogren's syndrome (cevimeline and pilocarpine)
Sweating, shivering, nausea, dizziness, increased frequency of urination, rhinitis (oral formulations)
Acute iritis or glaucoma after cataract extraction and narrow-angle (angle-closure) glaucoma |
|
|
Term
Carbachol, Bethanechol, Cevimeline, Pilocarpine, therapeutic considerations |
|
Definition
-Carbachol has enhanced nicotinic action relative to other choline esters; carbachol cannot be used systemically because of its unpredictable nicotinic action at autonomic ganglial topical application of carbachol to the cornea of the eye results in both pupillary constriction (miosis) and decreased intraocular pressure
-Bethanechol is almost completely selective for muscarinic receptors
-Pilocarpine and cevimeline (an M1 and M3 agonist) are used to treat xerostomia in Sjogren's syndrome |
|
|
Term
List Nicotinic Receptor Agonists and Mechanism |
|
Definition
Succinylcholine
Stimulate opening of nicotinic ACh receptor channel and produce depolarization of the cell membrane; succinylcholine presists at the neuroeffector junction and activates the nicotinic receptor channels continuously, which results in inactivation of voltage-gated sodium channels so that they cannot open to support further action potentials (sometimes called "depolarizing blockade") |
|
|
Term
Succinylcholine, applications, adverse effects, contraindications, therapeutic considerations |
|
Definition
induction of neuromuscular blockade in surgery and intubation
Bradyarrhythmia, cardiac arrest, cardiac arrhythmia, malignant hyperthermia, rhabdomyolysis, respiratory depression, muscle rigidity, myalgia, raised intraocular pressure
Personal or family history of malignant hyperthermia, skeletal muscle myopathies, upper motor neuron injury, extensive denervation of skeletal muscle
-Short duration of action makes succinylcholine drug of choice for paralysis during intubation
-Causes transient fasciculations |
|
|
Term
List of Muscarinic Receptor Antagonist |
|
Definition
Atropine
Scopolamine
Pirenzepine
Methscopolamine
Glycopyrrolate
Ipratropium
Tiotropium
Oxybutynin
Propantheline
Terodiline
Tolterodine
Fesoterodine
Trospium
Darifenacin
Solifenacin |
|
|
Term
Atropine, applications, adverse effects, contraindications, therapeutic considerations |
|
Definition
Anticholinesterase overdoes, acute symptomatic bradycardia, premedication for anesthetic procedure, excessive salivation and mucus secretion during surgery, antidote to mushroom poisoning
Cardiac arrhythmia, coma, respiratory depression, raised intraocular pressure, tachycardia, constipation, xerostomia, blurred vision
narrow-angle glaucoma
-A naturally occurring alkaloid found in the plant Atropa belladonna
-Mainly muscarinic activity, marginal nicotinic effect
-More effective at reversal of exogenous rather than endogenous cholinergic activity |
|
|
Term
Scopolamine, clinical applications, adverse effects, contraindications, therapeutic considerations |
|
Definition
Motion sickness, nausea, and vomiting
Alteration in heart rate, drug-induced psychosis, somnolence, xerostomiaa, blurred vision
narrow-angle glaucoma
-significant CNS effects
-Delivered via transdermal patch |
|
|
Term
Pirenzepine, Methscopolamine, Glycopyrrolate, clinical applications, adverse effects, contraindications, therapeutic considerations |
|
Definition
Peptic ulcer disease, surgically induced or vagally induced bradycardia (glycopyrrolate)
Cardiac arrhythmia, malignant hyperthermia, anaphylaxis, seizure, constipation, xerostomia, urinary retention, decreased sweating
gastrointestinal obstruction, narrow-angle glaucoma
-Alternative or additive agents to standard peptic ulcer disease therapies
-Methscopolamine and glycopyrrolate have delayed but measurable CNS and cognitive anticholinergic effects |
|
|
Term
Ipratropium, Tiotropium, clinical applications, adverse effects, contraindications, therapeutic considerations |
|
Definition
Chronic obstructive pulmonary disease (COPD) and asthma
Paralytic ileus, anaphylaxis, oropharyngeal edema, abnormal taste in mouth, xerostomia (nasal spray)
Hypersensitivity
-Ipratropium is more effective than beta-adrenergic agonists in the treatment of COPD, but less effective in treating asthma
-Relative to ipratropium, tiotropium has been shown to have similar, and possibly superior, efficacy as a bronchodilator in the treatment of COPD |
|
|
Term
Oxybutynin, propantheline, terodiline, tolterodine, fesoterodine, trospium, darifenacin, solifenacin, clinical applications, adverse effects, contraindications, therapeutic considerations |
|
Definition
Hyperreflexic and overactive bladder and urge incontinence
constipation, diarrhea, nausea, dry mouth, application-site erythema, pruritus, urinary retention
narrow-angle glaucoma, gastric retention, urinary retention
-Oxybutynin, propantheline, tolterodine, fesoterodine, and trospium are nonspecific muscarinic receptor antagonists, whereas darifenacin and solifenacin and selective M3 receptor antagonists
-Tolterodine may cause less dry mouth than oxybutynin, and the newer M3-selective agents darifenacin and solifenacin may cause less dry mouth and constipation than nonselective agents |
|
|
Term
List Nicotinic Receptor Antagonists |
|
Definition
Pacuronium
Tubocurarine
Vecuronium
Rocuronium
Mivacurium |
|
|
Term
Mechanism of Nicotinic receptor antagonists |
|
Definition
Selectively antagonize nicotinic receptors, thus preventing endogenous ACh binding and subsequent muscle cell depolarization (sometimes called "nondepolarizing blockade") |
|
|
Term
Pancuronium, Tubocurarine, Vecuronium, Rocuronium, Mivacurium, clinical applications, adverse effects, contraindications, therapeutic considerations |
|
Definition
Induction of neuromuscular blockade in surgery and intubation
Hypertension, tachyarrhythmia, apnea, bronchospasm, respiratory failure, salivation, flushing (mivacurium)
Hypersensitivity
-Pancuroium and tubocurarine are long-acting agents; vecuronium and rocuronium are intermediate-acting agents; mivacurium is a short-acting agent
-Nondepolarizing blocking agents have variable adverse effects associated with ganglionic blockade, which can be reversed by administration of AChE inhibitors |
|
|
Term
Trimethaphan, Mecamylamine, clinical applications, adverse effects, contraindications, therapeutic considerations |
|
Definition
Hypertension in patients with acute aortic dissection
Paralytic ileus, urinary retention, respiratory arrest, syncope, orthostatic hypotension, dyspepsia, diplopia, sedation
Trimethaphan - asphyxia, uncorrected respiratory insufficiency, neonates at risk for paralytic or meconium ileus, shock
Mecamylamine - coronary insufficiency, glaucoma, recent myocardial infarction, pyloric stenosis, renal insufficiency, patients treated with sulfonamides
-Mecamylamine and trimethaphan are administered when gaglionic blockade is desired; these drugs lower blood pressure while simultaneously blunting the sympathetic reflexes that would normally cause a deleterious rise in pressure at the site of the tear in case of aortic dissection |
|
|